new medication. There are no data to support a specific period of time for observation with pregnancy-compatible medications. Timing will vary depending on individual clinical factors; in clinical practice this is usually a minimum of several months. In women with RMD who are currently pregnant and have active disease that requires medical therapy, we strongly recommend initiating or continuing a pregnancycompatible steroid-sparing medication, as both active RMD and continuous high-dose